Stavanger, Norway

Guido Werner Alves

This inventor holds 1 USPTO granted patent and 1 published patent application and 5 EPO patents. Top assignee: St. John's University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guido Werner Alves. Retrieved from https://idiyas.com/inventor/guido-werner-alves-i5os2iea

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guido Werner Alves: Innovator in Alzheimer's Disease Diagnosis

Introduction

Guido Werner Alves is a notable inventor based in Stavanger, Norway. He has made significant contributions to the field of medical diagnostics, particularly in the area of Alzheimer's disease. His innovative work focuses on the use of circulating serum microRNA biomarkers for the diagnosis of this debilitating condition.

Latest Patents

Guido holds a patent titled "Circulating serum microRNA biomarkers and methods for Alzheimer's disease diagnosis." This patent encompasses biomarkers and methods for identifying, verifying, and confirming circulating serum-based microRNAs. The microRNAs, referred to as PARKmiRs, can effectively differentiate patients suffering from Alzheimer's disease (AD) from non-AD patients. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Guido is affiliated with St. John's University, where he continues to engage in research and development related to his patent. His work is pivotal in enhancing the understanding and diagnosis of Alzheimer's disease, which affects millions worldwide. His dedication to innovation in this field is commendable.

Collaborations

Guido collaborates with esteemed colleagues, including Simon Geir Möller and Ketan Patil. These partnerships foster a collaborative environment that enhances the research and development of new diagnostic methods.

Conclusion

Guido Werner Alves is a pioneering inventor whose work in Alzheimer's disease diagnosis through microRNA biomarkers is making a significant impact. His contributions to medical science are invaluable, and his ongoing research promises to further advance the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…